SKYEPHARMA SECURES PARTNER FOR ASTHMA DRUG

A A

SkyePharma has struck a long-awaited partnership deal for its biggest drug hope, saying U.S. group Kos Pharmaceuticals will help develop and market Flutiform for asthma in the United States.

The Scotsman (http://business.scotsman.com/latest.cfm?id=691142006)